Phase Studies Pave News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phase Studies Pave. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phase Studies Pave Today - Breaking & Trending Today

ONC201 Looks to Prove Efficacy in Trial For Rare H3K27M-Mutated Diffuse Midline Gliomas

Published: February 14, 2024

The dopamine receptor D2 antagonist ONC201 is under evaluation in patients with H3K27M-mutated diffuse midline glioma in the phase 3 ACTION trial.

Source: onclive.com

Related Topics:

North CarolinaUnited StatesUniversity Of PennsylvaniaUniversity Of North CarolinaStephen BagleyAshley SumrallHospital Of The University PennsylvaniaUniversity Of North Carolina Chapel HillAbramson Cancer CenterAtrium Health Carolinas Medical CenterAtrium Health Levine Cancer InstituteInternal MedicineMedical OncologyNorth Carolina Chapel HillPhase Studies PaveData Shows Tolerable Safety ProfilePatients With H3k27m Mutated Diffuse Midline GliomaAction TrialThe Hospital Of University PennsylvaniaUniversity Of North Carolina Chapel Hill